ScienceDex / Researcher record
Mark S Wallace
- University of California, San Diego · Anesthesiology (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2024
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $1M in linked award amounts across 2 award records · Award-linked rank #14468.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1899500Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2024 award categories
- Anesthesiology
FY2024 award records by amount
NIH award records listing Mark S Wallace as a PI. Multi-PI records show the full award amount for context.
- 5R44DK136492-02R44Co-investigatorCannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy$932.6Kaward amount
- 4U24NS115714-02U24Contact PICalifornia Clinical and Translational Pain Research ConsortiumUniversity of California, San Diego · Anesthesiology (NIH department code)$101.2Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Mark S Wallace as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardPure Green Pharmaceuticals, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Mark S Wallace.